Health Care

Valeant to Sell Assets for $2.12B to Ease Debt Load

Valeant Pharmaceuticals International is selling its Dendreon cancer treatment business and three skincare brands for $2.12 billion as the troubled Canadian drugmaker looks to reduce more than $30 billion in debt.

Obama Says Farewell As His Legacy Unravels

As President Barack Obama prepares to deliver his farewell address Tuesday night, he will attempt one final time to assign meaning to his presidency in front of a nation that overwhelmingly voted to usher in an era of change. As the full range of powers associated with the executive branch is transferred into Trump’s hands, the President-elect will begin to undo Obama's legacy starting with these executive orders.

Is Hillary Clinton Above the Law?

During an interview with the FOX Business Network’s Maria Bartiromo, California Republican lawmaker Darryl Issa provided detailed analysis of Hillary Clinton’s email probe.

Allergan CEO Promises to Keep Drug Prices Affordable

Allergan CEO Brent Saunders says drug price increases have to stop. During an interview with the FOX Business Network’s Maria Bartiromo he discussed Allergan’s “social contract with patients” to cap drug prices.

Merck CEO: Major Breakthrough in Lung Cancer Treatment

During an interview with the FOX Business Network’s Maria Bartiromo Merck CEO Kenneth Frazier said the company has found, based on new data released over the weekend, how its immune therapy drug Keytruda may help to fight advanced lung cancer.

Turing CEO Martin Shkreli Unapologetic for 5,000% Drug Price Hike

The price-gouging pharmaceutical CEO under fire for increasing the price of HIV/AIDS drug, Daraprim from $18 to $750 per pill is unapologetic. During an interview with the FOX Business Network’s Maria Bartiromo, Turing CEO Martin Shkreli explained what was behind the move.